Biognosys has released a new version of its SkinDig 100 MRM panel for mass spec-based quantification of 100 proteins in human skin biopsies and keratinocyte cell cultures.
The company said that it has adjusted the panel to include certain proteins of high relevance for dermatology research and has reduced coefficient of variation levels to less than 5 percent on average and 4 percent median.